Adaptive Biotechnologies (ADPT) R&D/CAPEX US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D/CAPEX, % | 617.3% | 230.5% | 867.1% | 949.7% | 1 992% | ||||
Changes by years, y/y, % | -14pp | -387pp | +637pp | -867pp | +8.9% |
Adaptive Biotechnologies. R&D/CAPEX, %
Adaptive Biotechnologies. R&D/CAPEX, changes, pp
Adaptive Biotechnologies (ADPT) R&D/CAPEX US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
R&D/CAPEX, % | 872.0% | 1 027% | 1 832% | 2 002% | 1 992% | |||
Changes by years, y/y, % | +173pp | +371pp | -1 228pp | +604pp | +887pp | |||
Changes by quarters, q/q, % | -243pp | +155pp | -1 027pp | +169pp |